The FDA today issued a notice warning of a recall of arterial perfusion cannula devices made by Edwards Lifesciences (NYSE: EW). Edwards offers its arterial perfusion cannulae for adult patients undergoing cardiopulmonary bypass. They provide arterial perfusion of oxygenated blood in the extracorporeal circuit for up to six hours. The company … [Read more...] about Edwards recalls certain arterial cannula devices
edwards
Edwards launches Sapien 3 valve with Alterra prestent in Europe
Edwards Lifesciences (NYSE:EW) announced that it launched its Sapien 3 transcatheter pulmonary valve implant (TPVI) system with Alterra adaptive prestent in Europe. The launch expands the continent’s minimally invasive treatment options to a broader range of patients with congenital heart conditions. Edwards recently received CE mark for … [Read more...] about Edwards launches Sapien 3 valve with Alterra prestent in Europe
